World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
60
Citations
12922
World Ranking
3328
National Ranking
227

Jacob Nattermann publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jacob Nattermann sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 348 publications — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jacob Nattermann D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jacob Nattermann sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 60 D-Index — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Jacob Nattermann is affiliated with University Hospital Bonn in Germany and has an extensive research portfolio primarily in the medical field. Their work covers a range of subfields including pathology and forensic medicine, infectious diseases, surgery, oncology, and epidemiology.

The researcher has published notably on topics related to genetic factors in colorectal cancer, COVID-19 clinical research studies, liver disease diagnosis and treatment, colorectal cancer screening and detection, SARS-CoV-2 and COVID-19 research, long-term effects of COVID-19, and liver disease and transplantation.

Nattermann's recent papers include:

  • Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment, 2020, Cell
  • Swarm Learning for decentralized and confidential clinical machine learning, 2021, Nature
  • Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19, 2020, Immunity
  • Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients, 2021, Genome Medicine
  • Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19, 2021, Immunity

Nattermann frequently collaborates with coauthors such as Christian P. Strassburg, Robert Hüneburg, Philipp Lutz, Benjamin Krämer, and Hans Dieter Nischalke.

Their publications appear regularly in journals such as Zeitschrift für Gastroenterologie, Journal of Hepatology, International Journal of Cancer, Infection, and Gastroenterology.

Best Publications

  • Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment.

    Jonas Schulte-Schrepping;Nico Reusch;Daniela Paclik;Kevin Baßler

  • BamQuery: A new proteogenomic tool to explore the immunopeptidome and validate tumor‐specific antigens

    Maria Virginia Ruiz;Anca Apavaloaei;Qingchuan Zhao;Marie-Pierre Hardy

  • A Polymorphism Near IL28B Is Associated With Spontaneous Clearance of Acute Hepatitis C Virus and Jaundice

    Hans L. Tillmann;Alex J. Thompson;Keyur Patel;Manfred Wiese

  • Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19.

    Joana P. Bernardes;Neha Mishra;Florian Tran;Thomas Bahmer

  • Functional Contribution of Elevated Circulating and Hepatic Non-Classical CD14+CD16+ Monocytes to Inflammation and Human Liver Fibrosis

    Henning W. Zimmermann;Sebastian Seidler;Jacob Nattermann;Nikolaus Gassler

  • Interleukin-8 is activated in patients with chronic liver diseases and associated with hepatic macrophage accumulation in human liver fibrosis.

    Henning W. Zimmermann;Sebastian Seidler;Nikolaus Gassler;Jacob Nattermann

  • Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C

    Jacob Nattermann;Georg Feldmann;Golo Ahlenstiel;Bettina Langhans

  • Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19.

    Benjamin Krämer;Rainer Knoll;Lorenzo Bonaguro;Michael ToVinh

  • Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients.

    Anna C. Aschenbrenner;Maria Mouktaroudi;Benjamin Krämer;Marie Oestreich

  • An internationally generalizable risk index for mortality after one year of antiretroviral therapy.

    Janet P Tate;Amy C Justice;Michael D Hughes;Fabrice Bonnet

  • The HLA-A2 Restricted T Cell Epitope HCV Core35–44 Stabilizes HLA-E Expression and Inhibits Cytolysis Mediated by Natural Killer Cells

    Jacob Nattermann;Hans Dieter Nischalke;Valeska Hofmeister;Golo Ahlenstiel

  • HIV-1 infection leads to increased HLA-E expression resulting in impaired function of natural killer cells.

    Nattermann J;Nischalke Hd;Hofmeister;Kupfer B

  • Interferon-lambda serum levels in hepatitis C.

    Bettina Langhans;Bernd Kupfer;Ingrid Braunschweiger;Simone Arndt

  • NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner

    Andreas Glässner;Marianne Eisenhardt;Benjamin Krämer;Christian Körner

  • The VACS Index

    Janet P Tate;Amy C Justice;Michael D Hughes;Fabrice Bonnet

  • IL28B, HLA-C and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a european cohort: A cross-sectional study

    Vijayaprakash Suppiah;Silvana Gaudieri;Nicola J. Armstrong;Kate S. O'Connor

  • Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease

    Mohammed Eslam;Ahmed M Hashem;Reynold Leung;Manuel Romero-Gomez

  • Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma.

    Bettina Langhans;Hans Dieter Nischalke;Benjamin Krämer;Leona Dold

  • Toll-like receptor (TLR) 2 promoter and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis

    H.D. Nischalke;C. Berger;K. Aldenhoff;L. Thyssen

  • Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis.

    Michaela Granzow;Robert Schierwagen;Sabine Klein;Benita Kowallick

  • The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis.

    Hans Dieter Nischalke;Cordula Berger;Carolin Luda;Thomas Berg

  • Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients

    Anna C. Aschenbrenner;Anna C. Aschenbrenner;Maria Mouktaroudi;Benjamin Krämer;Nikolaos Antonakos

  • Complement activation induces excessive T cell cytotoxicity in severe COVID-19

    Philipp Georg;Rosario Astaburuaga-García;Rosario Astaburuaga-García;Lorenzo Bonaguro;Sophia Brumhard

Frequent Co-Authors

Ulrich Spengler
Ulrich Spengler University of Bonn
Tilman Sauerbruch
Tilman Sauerbruch University of Bonn
Christian P. Strassburg
Christian P. Strassburg University Hospital Bonn
Jürgen K. Rockstroh
Jürgen K. Rockstroh University Hospital Bonn
Matthias Kloor
Matthias Kloor University Hospital Heidelberg
Achim Hoerauf
Achim Hoerauf University of Bonn
Joachim L. Schultze
Joachim L. Schultze University of Bonn
Jonel Trebicka
Jonel Trebicka University Hospital of Münster
Christoph Engel
Christoph Engel Leipzig University
Gregory J. Dore
Gregory J. Dore University of New South Wales

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying immunology in the USA opens doors to various healthcare and research careers, often requiring complementary degrees or certifications. Many professionals pursue advanced nursing paths, such as transitioning from family nurse practitioner (FNP) roles to more specialized fields. Resources like fnp to acute care certification offer guidance for those expanding their clinical expertise.

For those starting without a nursing background, enrolling in online bsn programs for non nurses provides an accessible pathway into nursing and healthcare, which can complement immunology studies.

Accelerated programs, such as the accelerated np program, are ideal for individuals looking to fast-track their careers and enter the workforce with advanced practical skills.

Understanding earning potential is also important. Examining data on dnp salary by state can help in planning and evaluating the financial benefits of advanced practice nursing degrees linked with immunology expertise.

Best Scientists Citing Jacob Nattermann

Trending Scientists

Recently Published Articles